Research ArticleTUMOR IMMUNOLOGY

Myeloid cell–synthesized coagulation factor X dampens antitumor immunity

See allHide authors and affiliations

Science Immunology  20 Sep 2019:
Vol. 4, Issue 39, eaaw8405
DOI: 10.1126/sciimmunol.aaw8405

Article Information

vol. 4 no. 39

PubMed: 
Published By: 
History: 
  • Received January 29, 2019
  • Revision received July 2, 2019
  • Accepted August 6, 2019
  • .

Author Information

  1. Claudine Graf1,2,3,
  2. Petra Wilgenbus1,
  3. Sven Pagel1,
  4. Jennifer Pott1,
  5. Federico Marini1,4,
  6. Sabine Reyda1,
  7. Maki Kitano2,
  8. Stephan Macher-Göppinger5,
  9. Hartmut Weiler6 and
  10. Wolfram Ruf1,2,*
  1. 1Center for Thrombosis and Hemostasis, Johannes Gutenberg University Medical Center, Mainz, Germany.
  2. 2Department of Immunology and Microbiology, Scripps Research, La Jolla, CA, USA.
  3. 3Department of Internal Medicine III, Johannes Gutenberg University Medical Center, Mainz, Germany.
  4. 4Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI), Johannes Gutenberg University Medical Center, Mainz, Germany.
  5. 5Institute of Pathology, Johannes Gutenberg University Medical Center, Mainz, Germany.
  6. 6Blood Research Institute, Blood Center of Wisconsin, Milwaukee, WI, USA.
  1. *Corresponding author. Email: ruf{at}uni-mainz.de, ruf{at}scripps.edu

Altmetric

Article usage

Article usage: September 2019 to November 2020

AbstractFullPdf
Sep 201922377121389
Oct 201911361232325
Nov 20192889138
Dec 20192269946
Jan 20201947933
Feb 20201765525
Mar 20201724011
Apr 20201395417
May 20201576721
Jun 2020126267
Jul 202068299
Aug 202057306
Sep 2020459116
Oct 2020718657
Nov 2020910766

Stay Connected to Science Immunology

Navigate This Article